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Background: Multi-allelic copy number variants include examples of extensive variation between individuals in the
copy number of important genes, most notably genes involved in immune function. The definition of this variation,
and analysis of its impact on function, has been hampered by the technical difficulty of large-scale but accurate
typing of genomic copy number. The copy-variable alpha-defensin locus DEFA1A3 on human chromosome 8
commonly varies between 4 and 10 copies per diploid genome, and presents considerable challenges for accurate
high-throughput typing.
Results: In this study, we developed two paralogue ratio tests and three allelic ratio measurements that, in
combination, provide an accurate and scalable method for measurement of DEFA1A3 gene number. We combined
information from different measurements in a maximum-likelihood framework which suggests that most samples
can be assigned to an integer copy number with high confidence, and applied it to typing 589 unrelated European
DNA samples. Typing the members of three-generation pedigrees provided further reassurance that correct integer
copy numbers had been assigned. Our results have allowed us to discover that the SNP rs4300027 is strongly
associated with DEFA1A3 gene copy number in European samples.
Conclusions: We have developed an accurate and robust method for measurement of DEFA1A3 copy number.
Interrogation of rs4300027 and associated SNPs in Genome-Wide Association Study SNP data provides no evidence
that alpha-defensin copy number is a strong risk factor for phenotypes such as Crohn’s disease, type I diabetes, HIV
progression and multiple sclerosis.
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The majority of human copy number variants (CNVs)
are simple di-allelic polymorphisms, generally involving
variable deletion of non-coding sequences. However, a
small but interesting subgroup of CNVs displays multi-
allelic polymorphism for the copy number of a gene or
cluster of genes. Examples include polymorphism for the
copy number of CCL3L1 and CCL4L1 [1-3], of FCGR3A
and FCGR3B [4,5], and of a cluster of human beta-
defensin genes on chromosome 8 [6-8]. In all these
cases, associations of gene copy number with important
medical phenotypes have been reported – of CCL3L1/
CCL4L1 with HIV infection [2,9-11], of FCGR3B with* Correspondence: john.armour@nottingham.ac.uk
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reproduction in any medium, provided the orsystemic autoimmune disorders [4,5], and of beta-
defensins with Crohn’s disease and psoriasis [12,13]. In
the case of Crohn's disease, the associations proposed
with the beta-defensin CNV have attracted controversy,
particularly related to the confidence with which CNV
states can be called [14,15].
Establishing robust evidence for these associations is
made considerably more difficult by the technical chal-
lenge of determining accurate measures of copy number
[16]. Although most severe when the copy numbers are
high, as in the case of the beta-defensins (2-12 copies),
accuracy of copy number measurement is still an im-
portant issue in the interpretation of association data
even when gene copy numbers are relatively low, as in
the case of CCL3L1/CCL4L1 (0-4 copies in Europe)
[17-22]. Typing copy number by real-time PCR may be
subject to errors that compromise the accuracy ofd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ences in the physicochemical state of DNA samples that
alter the relative behaviour of test and reference loci
[18,23]. At high copy numbers the level of relative precision
required to distinguish integer copy number states with ac-
curacy may simply be beyond the capabilities of real-time
PCR, however carefully it is performed [14,19]. For ex-
ample, measurement error of only about 10% in analysis of
a sample with a true copy number of 6 would result in an
incorrect integer call. The quality-control difficulty created
by performing case–control association studies of multi-
allelic CNVs is compounded by the observation that no
simple SNP tags that can act as surrogates for the deter-
mination of gene copy number have been identified to date.
Alternative approaches have been explored for the de-
termination of copy number at multi-allelic loci that are
simultaneously convenient, economic and accurate. For
some but not all such loci [16], MLPA appears to provide
an appropriate level of accuracy to call most integers cor-
rectly. Approaches involving Paralogue Ratio Tests (PRTs),
which determine the representation of a test locus relative
to a co-amplified reference locus, have also been success-
ful in determining accurate copy number measures for
even some of the more challenging loci [24-26]. Side-by-
side comparisons [14,27] appear to suggest greater accur-
acy of PRT compared with real-time PCR for robust and
reproducible determination of copy number at multi-
allelic CNVs. In addition to PRTs, measurement of paralo-
gous ratios for allelic variants (microsatellites or indels)
between variable repeats within a sample have also been
valuable in supplementing information on gene copy
number. PRT measurements in combination with allelic
variant ratios have previously been used successfully in
multiplex measurement systems for CCL3L1/CCL4L1
[26], FCGR3A/B [28] and beta-defensins [14,29].
The cluster of human alpha-defensin genes on chromo-
some 8 includes the genes DEFA1 and DEFA3, which are
copy-variable [7,30,31]. The genes DEFA1 and DEFA3 dif-
fer only by a single base substitution in the coding se-
quence, corresponding to a single amino acid difference
between the peptides encoded. These genes appear to be
interchangeable occupants of a 19 kb copy-variable repeat
unit, with both DEFA1 and DEFA3 gene number showing
variation. For this reason, Aldred et al. [30] suggested the
composite designation DEFA1A3 for the copy-variable
locus. The DEFA1 and DEFA3 genes lead (after proteolytic
processing) to the expression of three distinct antimicro-
bial peptides, generally designated as HNP-1, -2, and -3.
High levels of these peptides are found in the granules of
neutrophils [32,33], and a small-scale study has suggested
that the expression level of the peptides is correlated with
gene copy number [7].
Serious technical challenges are posed by the accurate
measurement of the multi-allelic copy number variationdisplayed by DEFA1A3, because most individuals have 6
or more repeats. A full characterisation of the variation
should also include a separate determination of gene copy
numbers for DEFA1 and DEFA3. Furthermore, the exist-
ence of one repeat per haplotype differing substantially in
sequence from others (the “partial repeat” [30]) makes ap-
plication of many standard methods problematic. These
factors may underlie the failure to score this CNV in the
WTCCC CNV study, which adopted very thorough and
carefully controlled approaches to CNV typing [34].
In this study, we apply and combine a range of measure-
ment methods to determine the copy number of
DEFA1A3, and to define the relative contribution of the
DEFA1 and DEFA3 gene variants. This work has allowed
us to derive a consistent characterisation of copy number
variation among 589 European samples. Our data allow us
to identify a single SNP that effectively tags low, medium,
and high-copy number states, which can therefore act as a
convenient surrogate for approximate DEFA1A3 gene
copy number in high-throughput studies.
Results
The copy-variable alpha-defensin genes DEFA1 and
DEFA3 are arranged in a variable tandem repeat on
chromosome 8, in which each haplotype carries a single
copy of a centromeric “partial” repeat and a variable
number (including zero) of 19 kb “full” repeat units
(Figure 1). Our measurements of copy number at DEFA1A3
were based on five independent measures – two
paralogue ratio tests (PRTs) and three measurements of
ratios between variants within the variable repeat array.
The ratio measurements included two examples of
indels (one of 5 bp, the other of 7 bp), as well as the
single-base substitution that distinguishes the variant
genes DEFA1 and DEFA3 (Figure 1).
We applied these PRT measurements to evaluate
DEFA1A3 copy number in 600 unrelated DNA samples
from Europeans (120 unrelated HapMap CEU phase 1
and 2 samples, and 480 samples from ECCAC HRC
plates 1-5), calibrating the PRT ratios against samples of
known copy number (see “Methods”). Of these 600 sam-
ples, 11 (1.83%) failed to produce adequate data (at least
two measurements, including at least one PRT measure-
ment), so that we obtained useful results for 589 unre-
lated European samples. Starting from “gold standard”
DNA samples for which total DEFA1A3 copy number
had been inferred from restriction fragment lengths [30],
we developed a secondary set of reference samples,
drawn from publicly available sources; these were vali-
dated both using multiple measurements against the ori-
ginal reference samples as well as segregation within
pedigrees (see below). These new reference samples
are specified in the Methods, and listed separately in
(Additional file 1: Table S2).
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Figure 1 Schematic map of the DEFA1A3 CNV region, based on the human genome assembly (March 2006, NCBI36/hg18), and
showing the expected structure of a 2-copy allele. DEFA1A3 genes are found in the copy-variable 19 kb full repeat sequence and (with
exactly one copy per haplotype) in the centromeric partial repeat. The positions of the three SNPs rs7825750, rs4300027 and rs4512398 in the
centromeric flanking DNA are indicated as a, b and c respectively. The specific measurement points used in this study in the determination of
copy number are shown as differently-shaped symbols below the relevant locations, with the nearby DEFA4 gene providing the reference locus
for the DEFA4 PRT measurement (triangles). The MLT1A0 PRT (star) has a target site only in full, and not partial, repeat sequences, and for this
reason measures one copy less per haplotype than the other assays; calibration of MLT1A0 PRT values is undertaken using the predicted total
repeat unit count per sample, for ease of comparison with other measures.
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Figure 2 Copy number estimates determined by MLT1A0 PRT1
plotted against the corresponding copy number measure from
DEFA4 PRT, showing the correlation between the two measures
(r2 = 0.731) and some evidence of clustering around integer
values of 4, 5 and 6.
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file 2 (see also Additional file 1, section 3). The individ-
ual accuracy of each PRT method can be assessed by
comparing the inferred unrounded copy number with
the integer copy number deduced from overall analysis
of each sample (see below) to give a normalised meas-
urement – for example, a PRT measurement of 6.3 for a
sample with a true copy number of 6 would have a
normalised value of 1.05. The distributions of PRT mea-
surements normalised relative to the (assumed) correct
value are shown in (Additional file 1: Figure S1a and
S1b). The two PRTs appear to exhibit similar levels of
variation around the mean value, with standard devia-
tions of normalised measurements of 0.114 and 0.12 for
MLT1A0 and DEFA4 PRTs respectively. The distribu-
tion of normalised values conforms well to a Gaussian
distribution over the central range of -2 < z < 2. How-
ever, normalised ratios from MLT1A0 PRT appear to
have an excess of outliers at z values below about -2; see
(Additional file 1: Figure S2a). The measures from the
two PRT systems (MLT1A0 and DEFA4, Figure 2) cor-
relate well with each other (r2 = 0.731), and although
there is some indication of clustering around integer
values for copy numbers of 4, 5 and 6, the clusters are
less distinct at higher copy numbers.
In addition to the PRT measurements, three allelic ra-
tio methods were developed. These are practically very
useful measures in verifying copy number measurements
because of their empirical accuracy, but can be limited
in the information they provide; for example, a ratio of
2:1 is consistent with a copy number of 3, but also any
multiple of 3. Examples of individual samples typed by
these methods, with corresponding inferences about
total copy number and variant constitution, are shown
in Table 1.Information was combined from different measure-
ments using a likelihood-based approach similar to that
employed by Aldhous et al. for beta-defensins [14].
Gaussian distributions were used to model the expected
outcomes relative to the true copy number. The
Table 1 Examples of integer copy number inference from PRT and ratio data
Sample ID MLCN Minimum
ratio (MR)
MLT1A0
PRT
DEFA4
PRT
indel5
ratio
indel5
integers
DefHae3
ratio
DefHae3
integers
7bpdup
ratio
7bpdup
integers
NA12751 7 511.47 7.07 7.03 1.32 4:3 2.38 5:2 0.41 2:5
C0052 8 152.11 8.30 7.70 1.07 4:4 5.66 7:1 0.60 3:5
NA12749 5 21.99 5.71 5.21 (No data) - 3.70 4:1 3.74 4:1
C0157 9 10.50 9.09 9.02 1.18 5:4 6.12 8:1 0.78 4:5
NA12778 6 3.26 (No data) 7.59 1.12 3:3 5.49 5:1 0.21 1:5
Examples of copy number inference from PRT and ratio data. For each sample the table shows the MLCN (maximum likelihood copy number) derived by
combining information from different measures (see text and Table 2) and the minimum ratio (MR) score indicating the confidence with which that copy number
is assigned. For the three ratio tests (indel5, DefHae3 and 7bpdup), the measured ratio is shown alongside the integer interpretation derived from the MLCN that
best fits the observed ratio. Samples are arranged in decreasing order of confidence, as reflected in decreasing values of the minimum ratio (MR).
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(MLT1A0 PRT, DEFA4 PRT, and ratios of alleles for
indel5 (5 bp deletion), 7bpdup (7 bp duplication), and
DEFA1:DEFA3) are combined by multiplication to derive
an overall measure of relative likelihood for each copy
number (Table 2). We refer to the copy number best
supported by the combined data as the “MaximumTable 2 Examples of ML analysis, showing copy numbers in t
Relative likelihood values
Measured
value
N = 2 N = 3 N
Sample NA12751 PRT1 (MLT1A0) 7.07 1.28E-139 2.84E-40 1.5
MLCN 7 PRT2 (DEFA4) 7.03 2.15E-137 1.97E-39 2.3
Minimum ratio
511.47
indel5 1.32 0.044 2.02E-03 0.0
DefHae3 2.38 5.67E-30 0.099 0.6
7bpdup 2.43 6.06E-06 0.343 0.1
Combined 4.87E-312 4.41E-83 1.7
N = 2 N = 3 N
Sample NA12749 PRT1 (MLT1A0) 5.71 6.56E-75 4.43E-18 5.9
MLCN 5 PRT2 (DEFA4) 5.21 3.29E-56 3.55E-12 0.1
Minimum ratio
21.99
indel5 (-) 1 1 1
DefHae3 3.70 2.95E-106 1.49E-12 0.0
7bpdup 3.74 9.24E-114 4.16E-12 0.1
Combined 0 2.08E-52 7.2
N = 2 N = 3 N
Sample C0157 PRT1 (MLT1A0) 9.09 1.22E-272 1.34E-89 9.0
MLCN 9 PRT2 (DEFA4) 9.02 3.54E-267 1.78E-87 3.7
Minimum ratio
10.50
indel5 1.18 0.503 1.62E-04 0.5
DefHae3 6.12 0 1.88E-63 6.2
7bpdup 0.78 0.194 1.54E-05 0.1
Combined 0 3.66E-247 6.7
Detailed examples of maximum likelihood analysis from samples NA12751 (7 copie
analysis evaluates probabilities associated with copy numbers up to 16, for clarity w
of an indel5 ratio provides no information about likely copy numbers, and so all co
for NA12749 is most consistent with a copy number of 5, so that (on the basis of th
below about 10-308 are rounded to zero (see Additional file 1).Likelihood Copy Number” (MLCN), and the factor by
which the support for that copy number exceeds the
next best copy number (the “minimum ratio”, MR) is an
index of confidence in the assignment of the copy num-
ber. Further details are given in the Additional file 1,
Section 1. The output from this analysis for the 589 sam-
ples typed in this study is available as Additional file 3.he range 2-10
for
= 4 N = 5 N = 6 N = 7 N = 8 N = 9 N = 10
0E-11 6.82E-04 0.276 1 0.471 0.091 0.012
7E-07 0.010 0.458 1 0.544 0.156 0.034
44 0.318 0.044 0.880 0.068 1 0.318
26 0.038 0.099 0.983 0.626 0.172 0.734
55 6.25E-03 0.343 1 0.155 0.343 0.970
6E-20 6.14E-10 2.20E-04 1 1.96E-03 9.67E-04 1.10E-04
= 4 N = 5 N = 6 N = 7 N = 8 N = 9 N = 10
9E-04 0.538 1 0.201 0.019 1.44E-03 1.16E-04
02 1 0.527 0.095 0.012 1.50E-03 2.00E-04
1 1 1 1 1 1
45 1 0.366 0.057 0.045 0.550 1
24 0.873 0.111 7.28E-03 0.124 0.863 0.873
5E-07 1 0.045 1.68E-05 2.72E-06 2.19E-06 4.31E-08
= 4 N = 5 N = 6 N = 7 N = 8 N = 9 N = 10
8E-31 2.19E-13 9.13E-06 0.022 0.478 1 0.612
3E-19 8.65E-09 5.47E-04 0.086 0.650 1 0.649
03 0.058 0.503 0.329 0.503 0.637 0.503
6E-18 7.72E-06 0.053 0.734 0.958 0.486 0.171
94 0.351 0.194 0.938 0.194 0.985 0.351
9E-67 9.71E-28 8.54E-11 1.37E-03 0.095 1 0.039
s), C0157 (9 copies) and NA12749 (5 copies) – see also Table 1. Although our
e only show values up to 10 here. For sample NA12749, note that the absence
py numbers are assigned an equal relative probability. The DEFA1:DEFA3 ratio
is measure alone) a copy number of 10 is equally well supported. Probabilities
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which integer copy numbers were assigned, with MR ran-
ging from just above unity (i.e., the assigned copy number
was only marginally favoured over an alternative) to sev-
eral million-fold. The median MR value was 20.1, and the
interquartile range was 3.78-133.1; most samples, there-
fore, were assigned an integer copy number that was sup-
ported by a factor of at least 3 over alternatives. Low
values of MR, corresponding to greater uncertainty in as-
signment to a particular integer, correlated as expected
with (a) missing or uninformative data and (b) high copy
number (see Additional file 1, Section 1d).
The analysis assumes that the same underlying copy
number applies to all the sequence elements measured.
To investigate whether any samples had evidence to the
contrary, we highlighted samples as anomalous if they in-
cluded one or more measure associated with a very low
probability (P < 5 × 10-4) for the maximum-likelihood copy
number. We found no evidence suggesting that any of the
seven cases found in this way resulted from the existence
of non-standard repeat units. Further discussion of this
point can be found in the Additional file 1, Section 1d.
The distributions of diploid copy numbers for the two
population samples examined (HapMap CEU [US] and
ECACC [UK]) did not differ significantly (P > 0.2), and
were therefore pooled to give an estimated distribution
of copy numbers that should be generally applicable to
white European populations (Table 3). At other mul-
tiallelic CNV loci, segregation has been powerful in val-
idating the accuracy of copy number measurements, as
well as in defining the constituent haplotypes of which
the diploid CNV total is composed [29,30]. We therefore
examined the segregation of DEFA1A3 copy number, ofTable 3 Distribution of diploid copy numbers from 589 Europ
previous studies
DEFA1A3
copy number
This study
(N = 589)
Observed
frequency
Predicted
frequency (HWE)
≤3 1 0.002 0.004
4 28 0.048 0.045
5 69 0.117 0.129
6 117 0.199 0.177
7 121 0.205 0.215
8 129 0.219 0.205
9 64 0.109 0.113
10 37 0.063 0.085
11 13 0.022 0.017
12+ 10 0.017 0.010
Distributions of diploid copy numbers in the 589 European samples typed in this w
Aldred et al. [30], Linzmeier and Ganz [7], and Nuytten et al. [52]. The comparison is
those predicted from the haplotype frequencies determined in this study, assuming
of copy number classes were not given explicitly by Nuytten et al. [52], but are reco
do not give details of individual copy number counts, but instead give counts abovthe inferred numbers of DEFA1 or DEFA3 alleles, and of
indel alleles, in three-generation CEPH pedigrees (of
which one example is shown in Figure 3). In 17 out of
23 families analysed in this way, all four parental haplo-
types and their segregation could be inferred unambigu-
ously from our observations alone, but in others
haplotypes were resolved using the correct segregation
pattern for the region as deduced from flanking SNP ge-
notypes in CEPH families (http://www.cephb.fr/en/
cephdb/browser.php), which were also used to confirm
the grandparental origins of the parental haplotypes, and
hence deduce the identities of the four grandparental
haplotypes that were not transmitted to the parents. De-
termining frequencies of 179 haplotypes from segrega-
tion data allowed us to predict the expected frequencies
for different diploid copy numbers under Hardy-
Weinberg equilibrium. These predicted frequencies
(Table 3) are not significantly different from those ob-
served (P = 0.28).
Comparison of haplotype copy numbers for CEU sam-
ples included in the HapMap project allowed us to investi-
gate association between DEFA1A3 copy number and local
SNPs. The strongest association was with rs4300027, in a
pattern corresponding to association of C at rs4300027
with 2- and 3-copy haplotypes, and T with 4- and 5-copy
haplotypes. We therefore typed rs4300027 in the 589 sam-
ples for which we had determined copy number. A clear
and strong association between rs4300027 and the copy
number of alpha-defensin genes was confirmed, with the
SNP genotype at rs4300027 approximately partitioning
European samples into low (CC), medium (CT) and high
(TT) copy number categories (Figure 4b: P = 1.3 × 10-45).
This association is not absolute; some examples ofean samples typed in this work, and comparison with
Reconstructed from
Aldred (N = 111) Linzmeier (N = 27) Nuytten (N = 344)
0 0 0.006
0.027 0 0.037
0.144 0.037 0.192
0.261 0 0.372
0.243 0.111 0.257
0.198 0.111 0.087
0.108 0.111 0.043
0.009 0.259 0.006
0.009 0.074 0
0 0.296 0
ork, and comparison with data taken or inferred from the previous studies of
also made between the observed frequencies of copy number classes and
Hardy-Weinberg equilibrium (“Predicted frequency (HWE)”). The frequencies
nstructed here from the data in their Figure seven (a). Jespersgaard et al. [47]
e or below a copy number of 6.
Total CN
Haplotype ID
Haplotype CN
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Figure 3 Segregation of haplotypes in the three-generation CEPH family 1341. In addition to the copy number, segregating haplotypes
(boxed) are distinguished by the composition of other variants for which ratios were determined in this study. In this figure, only the DEFA3
content of each haplotype is shown (as the figure at the bottom of the haplotype box), but other variants can also be used to distinguish and
characterise the haplotype content. In this family, both parents possess a 3-copy haplotype (haplotypes A and C), but they are distinguished by
the fact that only the haplotype (A) carried by the father contains a copy of DEFA3.
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4- and 5-copy individuals with rs4300027 genotype CT.
These observations have been repeated and individually
verified as genuine, and cannot therefore be attributed to
inaccurate typing of copy number or of SNP genotype. Al-
though the correlation illustrated in Figure 4b appears con-
sistent, a (three-state) SNP genotype will always have
limited ability to tag a multi-state CNV, and indeed
the statistical power of rs4300027 genotype to predict
DEFA1A3 CNV status is indeed relatively modest (r2 =
0.35).
The definition of a SNP tagging DEFA1A3 copy num-
ber allows us to perform indirect association tests by in-
terrogating existing GWAS SNP data. If a clinical
phenotype is strongly associated with DEFA1A3 copy
number, this should be indirectly reflected in an associ-
ation with genotype at rs4300027, or the associated
neighbouring SNPs rs4512398 (in near-complete LD
with rs4300027 in European populations) and rs7825750
(r2 = 0.46 with rs4300027). Indeed, because of the strong
but imperfect correlation with SNPs, a genuine under-
lying association with DEFA1A3 copy number may be
manifest in GWAS data as a P value (for example, in the
range 10-4 to 10-7) too high to merit attention in a
genome-wide context. Complete GWAS data, listing P
values for all SNPs typed, were available from the
WTCCC [35] and the CHAVI GWAS study of HIV con-
trol [36], and we obtained the assistance of relevant in-
vestigators in examining data from GWAS studies ofatopic dermatitis [37], coeliac disease [38], Crohn’s dis-
ease [39,40], type 1 diabetes [41], lung function in cystic
fibrosis [42], multiple sclerosis [43], psoriasis [44,45] and
ulcerative colitis [40,46]. These were interrogated for P
values with rs4300027 or rs4512398 where genotyped,
and rs7825750 in other studies. The results are collated
in Additional file 1: Table S3, and reveal no strong indi-
cation of association with the DEFA1A3 CNV as
reflected indirectly in SNP data. It is noteworthy that for
each of Crohn’s disease, psoriasis and type I diabetes
there are two independent studies listed in Additional
file 1: Table S3 that fail to show a significant association.
Although the simplest explanation of these outcomes is
that these phenotypes are not influenced by DEFA1A3 copy
number, even well-powered GWAS have limited power to
positively exclude an association, especially at low effect
sizes. Only coeliac disease (P = 0.013) demonstrated a P
value below 0.05 (with rs4512398), but given that 18 differ-
ent studies were examined, even that cannot be viewed as
significant once a correction has been made for multiple
testing (Additional file 1: Table S3). The relationship be-
tween CNV status and flanking SNPs might be different in
different populations, and we therefore examined separ-
ately the largest single (UK) cohort in the study of Dubois
et al. [38], consisting of 2586 cases of coeliac disease and
7532 controls; in this alternative analysis, the association
with rs4512398 was not significant (P = 0.29).
We can therefore use these observations to suggest
that a strong influence of DEFA1A3 copy number on
ab
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Figure 4 Frequencies of measured integer DEFA1A3 copy
number states in Europeans. (a) Histogram of copy number
frequencies in 589 European DNA samples, (b) subdivided according
to rs4300027 genotypes.
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populations is unlikely, despite the published evidence
suggesting the influence of DEFA1A3 copy number in
Crohn’s disease [47] and of increased alpha-defensin pro-
duction on HIV progression [48]. It also provides a simple
(SNP-based) method for further investigation of other phe-
notypes in which DEFA1A3 copy number may be impli-
cated, such as the published association with sepsis [49], in
a way that would not be complicated by the difficulties of
direct copy number measurement. Nevertheless, although
SNP genotyping can be used as an aid to prioritisation, be-
cause the association between rs4300027 and the CNV is
imperfect, direct typing of the CNV remains the only de-
finitive way to investigate potential associations.Discussion
In the absence of high-throughput methods that confer
absolute assurance of gene copy number, detailed assess-
ment of the accuracy of a new typing methodology is es-
sential before it can be used in large sample sets. Having
defined the copy number of some reference standard
samples using definitive methods such as PFGE, these
can be then used to calibrate and test further experi-
ments. In addition, the evaluation of accuracy requires
careful analysis of the internal consistency of data de-
rived from the integration of different measurement as-
says. In principle, to achieve the best typing quality,
large-scale association studies should ideally use pulsed-
field gel analysis, but in practice few studies have the
DNA resources, equipment and personnel to undertake
the kind of exemplary work done at the complement C4
locus [50,51]. In particular, wider replication of associ-
ation findings generally depends on a reliable but high-
throughput method to type DNA samples of the kind
found in most population sampling studies.
Most DEFA1A3 repeat alleles appear to harbour between
1 and 5 copies of a 19 kb copy-variable repeat, which al-
lows different copy number alleles to be clearly distin-
guished after pulsed-field gel electrophoresis [30]. We were
therefore able to use samples that had been definitively
typed by this method [30] as the starting-point for calibrat-
ing our methods; subsequent analysis of segregation in
three-generation pedigrees defined further reference sam-
ples that displayed unambiguous copy numbers on re-
peated testing using PRT and ratio methods (Figure 3).
Larger-scale typing then produced data that were internally
consistent between PRT and ratio measurements and
conformed well to the predictions of Hardy-Weinberg
equilibrium using haplotype frequencies determined in
three-generation families. Reassurance of the correct cali-
bration of our typing methods is particularly important
given the apparent differences with the population copy-
number distributions discovered by other approaches
[7,47,52].
The copy-number frequencies found in this study are
similar to those determined by Aldred et al. [30] who
used a combination of MAPH and variant ratios, and al-
though there are some differences (such as a higher fre-
quency of copy numbers above 10 in the present work)
the overall distribution is not significantly different (P =
0.073). By contrast, the differences between our data and
the distribution given by Linzmeier and Ganz [7] based
on real-time PCR measurements are highly significant
(Table 3), especially in the representation of copy num-
bers above 8 (P = 1.95 × 10-10). Although it is possible
that different population origins may influence the out-
come, even the relatively small sample analysed by
Linzmeier and Ganz seems incompatible with the values
determined here, and may reflect limitations of real-time
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[52] used real-time PCR calibrated against concatemeric
constructs, but reports a copy number distribution that
is also very significantly different from the one reported
here (P = 1.1 × 10-10), with a much lower frequency of
samples with copy numbers above 8. Nuytten et al. do
not use reference genomic DNA standards, and despite
their careful and ingenious method to calibrate real-time
PCR measurements, it is possible that in this case their
cloned constructs do not produce the same calibration
as would be obtained from genomic DNA samples of
the same copy number. The real-time PCR results from
Danish samples given by Jespersgaard and colleagues
[47] also have significantly more samples of low copy
number (6 or fewer) among controls than we find in Eu-
ropeans (P = 5.6 × 10-3), but not among their samples
from Crohn’s disease patients (P = 0.074). Our prelimin-
ary analysis (data not shown) demonstrates a strong cor-
relation with integer copy numbers published recently
for HapMap Chinese and Japanese samples by Cheng
et al. [53], although without further information on
measurement variation or consistency for their real-time
PCR assay it is not possible to judge the extent or causes
of differences between our results.
In principle, read-depth analysis provides an alterna-
tive method to establish definitive diploid gene copy
number for a sample, and the study of Sudmant et al.
[54] first used genome-wide analyses of read depth to
define copy number variation profiles for individual
DNA samples. Although the available data suggest that
their analysis of the DEFA1A3 CNV is broadly compar-
able with ours (median copy number of 7.58 in Table S7
of Sudmant et al., median value 7 in this study), no indi-
vidual copy number values are given by Sudmant et al.,
and their sample of 159 individuals comes from diverse
global populations [54]. There were eight samples typed
in our study which have also been sequenced as part of
the Complete Genomics CNV Genome Baseline Set
[55]. Our copy numbers for these samples have a strong
correlation (r2 = 0.93) with the recorded sequence cover-
age (for further details see Additional file 1, Section 2).
Microarray data for 108 HapMap samples from Camp-
bell et al. [56] (their Supplementary Table S7) correlate
reasonably well with our results (r2 = 0.49), even though
the DEFA1A3 CNV does not form discrete genotype clas-
ses in their analyses, and the absolute copy numbers are
calibrated by comparison of microarray signals against
single-copy regions rather than specifically against known
DEFA1A3 copy numbers. Presumably for this reason,
Campbell et al. report copy number ranges for DEFA1A3
higher than measured in this study (mean 9.5 and median
9.4, compared with 7.5 and 8 respectively in this study).
These analyses are described in Additional file 1, Section
2, and illustrated by a scatterplot in Additional file 1:Figure S4. Although the DEFA1A3 CNV was not called in-
dividually in the 42 million-element array-CGH study of
Conrad et al. [57], their publicly available data can be
compared with our own results for 17 samples, in which a
good correlation (r2 = 0.74) is found (see Additional file 1,
Section 2, and Additional file 1: Figure S5). The CNV at
DEFA1A3 does not seem to have been defined and
analysed in other recent studies on genome-wide identifi-
cation of CNVs through read-depth analysis [58,59].
By comparison with flanking SNP genotypes in HapMap
samples we were able to define a strong association be-
tween DEFA1A3 copy number and rs4300027. To a first
approximation this single SNP partitions our samples into
classes with low (up to 6 copies), medium (6 to 8 copies)
and high (8 copies or more) copy number, although initial
further work suggests that this is not a simple cladistic
split into high- and low-copy lineages (data not shown). In
addition to its practical power in exploring possible associ-
ations of DEFA1A3 copy number with disease phenotypes,
the strength and consistency of this association provides
additional reassurance that our copy number typing is not
subject to wide variation in accuracy. It is important to
note that the samples analysed here are of European ori-
gin, and so rs4300027 can be used with confidence as a
surrogate for DEFA1A3 copy number only in European
cohorts. Most published GWAS data sets do indeed ana-
lyse European subjects, but our initial exploration of the
HapMap samples suggests that the strong association of
rs4300027 with copy number is not reproduced in Asian
or African populations.
Conclusions
We have developed a PCR-based methodology for copy
number measurement of the human alpha-defensin
DEFA1A3 gene cluster. Our data show good internal evi-
dence of accuracy and consistency, and we have discov-
ered that DEFA1A3 copy number is strongly associated
with SNP rs4300027 in European samples. This has in
turn led to the application to GWAS investigations of
rs4300027 genotype as a good proxy for approximate
copy number range in Europeans.
Methods
DNA samples and standards
180 CEPH samples from the International HapMap
phase I and II (http://ccr.coriell.org) and 480 random
UK samples from the European Collection of Cell Cul-
tures (ECACC) Human Random Control (HRC) panels
1 to 5 (http://www.hpacultures.org.uk) were used to de-
velop the copy number measurement assays. The CEPH
(CEU) samples used consist of 56 family trios, 5 duos
and 2 singletons. For the data presented in the Results,
only the 120 unrelated HapMap CEU samples were con-
sidered, so that we attempted to type 600 unrelated
Khan et al. BMC Genomics 2013, 14:719 Page 9 of 12
http://www.biomedcentral.com/1471-2164/14/719European samples, of which 589 produced satisfactory
results. A further 110 individual CEPH samples were
used to infer segregation of the CEPH trios from
HapMap samples and another 99 individual CEPH sam-
ples from 3-generation pedigrees not included in the
HapMap project were also used for segregation. The 23
CEPH families for which further samples were available
and thus allowed segregation were; 12, 66, 104, 884,
1331, 1332, 1333, 1334, 1340, 1341, 1344, 1345, 1346,
1350, 1362, 1375, 1408, 1416, 1420, 1421, 1424, 1454,
13292. All DNA provided was extracted from lympho-
blastoid cell lines.
In initial development our typing methods were cali-
brated using the reference samples of known DEFA1A3
copy number defined by Aldred et al. [30] after pulsed-
field gel electrophoresis and Southern blotting. These
samples were used to define a second set of reference
samples, this time from publicly-available sources. After
initial calibration against the original pulsed-field gel-
typed reference samples, the copy numbers of these new
reference samples were confirmed by consistency of nu-
merous repeated measurements using different methods,
and by analysis of segregation within three-generation
families (see Results below). The data reported in this
paper were obtained by calibration against these new
reference samples. The new reference samples were four
samples available from the ECACC HRC-1 collection,
C0007 (7 copies), C0075 (6 copies), C0150 (8 copies)
and C0877 (9 copies), with three offspring from CEPH
pedigrees (DNA available from Coriell), NA07062
(=1340-3, 5 copies), NA11998 (=1420-4, 6 copies) and
NA07008 (=1340-5, 7 copies).
PCR and PRT methods
All PCR used 10 ng of input DNA, and a standard
buffer at a final concentration of 50 mM Tris–HCl
(pH8.8), 12.5 mM ammonium sulphate, 7.5 mM 2-
mercaptoethanol, 125 μg/ml BSA, 1.4 mM MgCl2, and
200 μM each dNTP. PCR products were denatured in
10 μl formamide containing ROX-500 markers (Life Tech-
nologies) before denaturation (96°C, 3 minutes) and capil-
lary electrophoresis. Although other combinations are
possible, our work combined 1 μl each of FAM- and
NED-labelled MLT1A0 PRT products with 1 μl of indel5,
followed by electroinjection at 1 kV for 30 seconds into an
ABI 3130xl Genetic Analyzer. Similarly, 4 μl of MspI-
digested DEFA4 PRT PCR product and 4 μl HaeIII-
digested DefHae3 PCR product were added to 10 μl
formamide/ROX mixture, with injection at 2 kV for 45 sec-
onds. GeneMapper software (Applied Biosystems) was used
to extract the peak areas of the separated PCR products.
MLT1A0 PRT was performed using two independent
PRT assays, one with a FAM labelled forward primer
and the other with a NED labelled forward primer, thatare then averaged into a single unrounded copy number
value. Each PCR was performed with 1 μM each
of primers (FAM/NED)-CCCAGAGAGCTCCTTC and
GTGACTTATAAACAACAAAAA, using 24 cycles of
95°C for 30 seconds, 48°C for 30 seconds and 72°C for
30 seconds, followed by a 10-minute hold at 72°C. The
primers amplified from an MLT1A0 dispersed repeat
present in full repeats (only, see Figure 1) at DEFA1A3
and a similar repeat at the reference locus on chromo-
some 1. The MLT1A0 PRT gives products of 170 bp for
the reference locus on chromosome 1 and 167 bp for
the full repeat region of DEFA1A3.
DEFA4 PRT used 1 μM primers TGCTCCTGCT
CTCCCTCCT and (HEX)- TTGGAATCAAGTCTTT
GGAGAAA, amplifying for 26 cycles of 95°C for 30 sec-
onds, 56.5°C for 30 seconds and 70°C for 30 seconds,
followed by a 70°C hold for 10 minutes. This PCR ex-
ploits sequence similarities between the closely related
genes DEFA1A3 and DEFA4, such that the primers were
specifically designed to match sequences in both genes,
giving products of 404 bp for the reference locus and
406 bp for DEFA1A3. These products cannot be com-
pletely separated by electrophoresis, and therefore an
overnight restriction digestion at 37°C by MspI was
performed which gives labelled products of 275 bp for
the DEFA4 reference locus and 317 bp for DEFA1A3. Al-
though we have observed a single instance of a haplo-
type carrying a deletion of DEFA4, no further examples
of this variant have been observed (see Additional file 1,
section 1(d)).
Ratio methods
The ratio between the DEFA1 and DEFA3 gene variants
was measured using an assay (“DefHae3”) exploiting the
HaeIII restriction site difference between them. PCR
used 1 μM of primers TGTCCCAGGCCCAAGGAAAA
and FAM- TCCCTGTAGCTCTCAAAGCA, using 25 cy-
cles of 95°C for 1 minute, 58°C for 1 minute and 70°C
for 1 minute, followed by a 70°C hold for 10 minutes.
The underlined base in the forward primer is a deliber-
ate mismatch with the genomic sequence to create an
artificial site for HaeIII. Because a completely undigested
product arising from incomplete activity of the restric-
tion enzyme cannot otherwise be distinguished from the
(DEFA3) variant lacking an internal HaeIII site, it was
necessary to introduce this artificial site into all products
to act as a check of complete digestion by HaeIII.
DEFA1 (HaeIII+) products yield a labelled product of
144 bp, and DEFA3 (HaeIII−) products 161 bp. PCR
product (5 μl) was digested with 1.5U HaeIII in a total
volume of 15 μl at 37°C for 12-16 hours. The full-length
PCR product, indicating incomplete digestion, would be
170 bp. The DefHae3 ratio recorded is the ratio of
144 bp to 161 bp products, i.e., the DEFA1:DEFA3 ratio.
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basis of the “indel5” ratio assay. Indel5 PCR used 1 μM
of primers HEX-CTGTCCAGGAAGAGGGAGAG and
CAGCTGGAGGGTCTCTGTTC, and 23 cycles of 95°C
for 30 seconds, 57°C for 30 seconds and 70°C for 30 sec-
onds, followed by a 70°C hold for 10 minutes to generate
amplicons of 124/129 bp. The indel5 ratio recorded is
the ratio of deleted (124 bp) to undeleted (129 bp)
products.
A 7 bp duplication variant present in many repeat units
provided the basis of a third (“7bpdup”) ratio measure-
ment. This assay used primers (HEX)- AGCAAAAATCA
AACAACCTGA and GCTATGCCTCCAATCTGACC;
after an initial denaturation of 95°C for 1 minute, products
were amplified for 24 cycles of 95°C for 30 seconds, 54°C
for 30 seconds and 70°C for 30 seconds, followed by a final
hold at 70°C for 40 minutes. The 7bpdup ratio recorded is
the ratio of unduplicated (275 bp) to duplicated (282 bp)
products.
Genotyping of SNP rs4300027
Genotyping of rs4300027 was performed by PCR-RFLP.
A single PCR reaction was performed with 1 μM each of
primers AGATACCATGCTTGGAGGAA and GGGTC
TTGAATTCAAATGTCAG. PCR cycle conditions were
36 cycles of 95°C for 30 s, 58.6°C for 30 s, 70°C for 30 s to
generate an amplicon of 1043 bp in length. In the *C al-
lele this is cleaved by HinfI to produce 6 fragments of
439 bp, 174 bp, 154 bp, 116 bp and 105 bp, as well as a
small fragment of 55 bp. The second cleavage fails to
occur in the presence of the *T allele and so a product of
613 bp is observed, as well as the other small (154 bp,
116 bp, 105 bp and 55 bp) fragments. The distinction
between the longer allelic digestion fragments of 439 bp
and 613 bp is clearly visible on a 2% (w/v) agarose gel.
Data analysis
PRT ratios were used to estimate gene copy number values,
calibrating against reference samples of known copy num-
ber as described [24]. These PRT copy number values were
combined with ratio values for the same sample (from the
indel5, DEFA1: DEFA3 and 7bpdup ratio measurements) to
evaluate the most likely individual integer gene copy num-
ber. Briefly, for each PRT or ratio measurement, Gaussian
models of measurement error (based on empirical observa-
tions) were used to estimate the probability of producing
the actual measurement, given a particular value for the
true gene copy number between 2 and 16. Once these
probabilities had been determined for each measurement at
each copy number, they were combined by multiplication
to identify the integer copy number that maximises the
joint probability of all the data, the “maximum likelihood
copy number (MLCN)”. Further details can be found in
Additional file 1.For inclusion in the analysis, a sample needed to have
at least two non-zero data points, of which at least one
was a PRT. Out of the 600 DNA samples initially tested,
589 (98.2%) met these criteria.
Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article (and its additional files).
Additional files
Additional file 1: Further details on data analysis, including
Supplementary Figures and Tables. More detailed explanation and details
are given about the methods used in analysing the data (Section 1), and on
comparison with read-depth data from Complete Genomics (Section 2).
Additional file 2: Measured values for 589 European samples. This
file shows the measurements obtained for the 589 samples examined in
this study. The PRT values shown (MLT1A0 PRT and DEFA4 PRT) are
unrounded copy number estimates after calibration against reference
standards. The ratios (indel5, DefHae3, 7bpdup) are shown as the raw
uncalibrated ratios derived directly from the peak measurements. In this
datafile (and Additional file 3) “0” is used as a catch-all indicator of the
absence of information – either because no result was obtained, or
because only one of the two peaks was present for the ratio
measurements. In no case was a true value of 0 ever actually measured
for either PRT.
Additional file 3: Maximum-likelihood analysis of data from
Additional file 2. This file shows the maximum-likelihood analysis results
for the same 589 samples based on the input data shown in Additional
file 2. For each sample in turn, the input data are listed in column B, and
the Maximum-Likelihood Copy Number (MLCN) and minimum ratio in
columns C and D. The remaining columns show the individual relative
probabilities for each putative copy number based on each of the
measurements, with the “Combined” line at the top of each group giving
the compound probabilities. As in Additional file 2, a value of “0” can
indicate either missing data or an uninformative outcome, rather than a
measured copy number of 0. Probability values below about 10-308 are
rounded to zero.
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